We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-17.45%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$150M
AUM Growth
-$6.08M
Cap. Flow
+$16.2M
Cap. Flow %
10.8%
Top 10 Hldgs %
72.77%
Holding
404
New
15
Increased
152
Reduced
43
Closed
20

Top Buys

Rank Stock Value
1
RWL icon
Invesco S&P 500 Revenue ETF
RWL
+$11.3M
2
MSFT icon
Microsoft
MSFT
+$691K
3
DE icon
Deere & Co
DE
+$568K
4
AAPL icon
Apple
AAPL
+$508K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$462K

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$206K
2
BIIB icon
Biogen
BIIB
+$151K
3
NKE icon
Nike
NKE
+$122K
4
CMCSA icon
Comcast
CMCSA
+$98.5K
5
CONE
CyrusOne Inc Common Stock
CONE
+$83K

Sector Composition

Rank Sector Weight
1 Technology 10.7%
2 Consumer Discretionary 4.83%
3 Healthcare 4.56%
4 Financials 4.22%
5 Communication Services 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
51
Honeywell
HON
$77B
$293K 0.2%
1,788
+10
+0.6% +$1.8K
CVS icon
52
CVS Health
CVS
$133B
$291K 0.19%
3,137
+9
+0.3% +$878
BAC icon
53
Bank of America
BAC
$435B
$282K 0.19%
9,048
+127
+1% +$4.57K
IDXX icon
54
Idexx Laboratories
IDXX
$44.1B
$281K 0.19%
800
QCOM icon
55
Qualcomm
QCOM
$155B
$278K 0.19%
2,174
+1,241
+133% +$169K
ULTA icon
56
Ulta Beauty
ULTA
$22B
$276K 0.18%
715
+99
+16% +$39.3K
XOM icon
57
ExxonMobil
XOM
$644B
$272K 0.18%
3,176
+38
+1% +$3.43K
ABBV icon
58
AbbVie
ABBV
$443B
$263K 0.18%
1,720
+10
+0.6% +$1.53K
DRI icon
59
Darden Restaurants
DRI
$23.3B
$260K 0.17%
2,295
+230
+11% +$28.7K
LOW icon
60
Lowe's Companies
LOW
$117B
$257K 0.17%
1,474
+3
+0.2% +$578
PEY icon
61
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
$256K 0.17%
12,448
+120
+1% +$2.57K
EA icon
62
Electronic Arts
EA
$53B
$255K 0.17%
2,093
+3
+0.1% +$383
NOBL icon
63
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$248K 0.17%
5,812
+4,150
+250% +$189K
WMB icon
64
Williams Companies
WMB
$87.5B
$243K 0.16%
7,797
+6,740
+638% +$233K
CLX icon
65
Clorox
CLX
$11.6B
$242K 0.16%
1,715
+13
+0.8% +$1.86K
ELV icon
66
Elevance Health
ELV
$81.5B
$242K 0.16%
502
+2
+0.4% +$989
BA icon
67
Boeing
BA
$171B
$241K 0.16%
1,760
-409
-19% -$60.3K
CMCSA icon
68
Comcast
CMCSA
$85B
$230K 0.15%
5,863
-2,298
-28% -$98.5K
GE icon
69
GE Aerospace
GE
$374B
$230K 0.15%
5,786
+37
+0.6% +$1.79K
MS icon
70
Morgan Stanley
MS
$331B
$227K 0.15%
2,991
+1,178
+65% +$96.5K
XYZ
71
Block Inc
XYZ
$48.4B
$222K 0.15%
3,607
PAYC icon
72
Paycom
PAYC
$7.64B
$206K 0.14%
735
ZTS icon
73
Zoetis
ZTS
$32.4B
$203K 0.14%
1,179
ABT icon
74
Abbott
ABT
$183B
$200K 0.13%
1,844
+2
+0.1% +$227
C icon
75
Citigroup
C
$222B
$194K 0.13%
4,218
+1,950
+86% +$97.5K

Similar funds

Kozak & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Kozak & Associates held 404 positions worth $150M, down 3.9% from $156M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Kozak & Associates deployed $16.2M of net new capital in Q2 2022, opening 15 new positions and adding to 152 existing holdings. Its largest new stake was TC Energy: 3,358 shares worth $174K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was MPLX, an estimated $206K trimmed.

  • Kozak & Associates's largest Q2 2022 buy was TC Energy: 3,358 shares worth $174K.
  • Kozak & Associates added most to Invesco S&P 500 Revenue ETF in Q2 2022, an estimated $11.3M increase.
  • Kozak & Associates's biggest Q2 2022 reduction was MPLX, cutting an estimated $206K.
  • Kozak & Associates fully exited CyrusOne Inc Common Stock in Q2 2022, selling an estimated $83K.
  • Kozak & Associates's ten largest holdings make up 73% of its $150M portfolio in Q2 2022.
  • Kozak & Associates opened 15 new positions and closed 20 in Q2 2022.
  • Kozak & Associates's portfolio value fell 3.9% quarter-over-quarter to $150M.

Based on Kozak & Associates's 13F filing for Q2 2022, filed 12 Oct 2022.